Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CODOX-M and IVAC in Burkitt's Lymphoma
NCT00040690Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Nov 2008
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, vincristine, doxorubicin, methotrexate, ifosfamide in Burkitt lymphoma (BL), Burkitt leukemia, sponsored by Medical Research Council. Started Nov 2008; status: completed.
02
Drugs
cyclophosphamidevincristinedoxorubicinmethotrexateifosfamide
03
Conditions
Burkitt lymphoma (BL)Burkitt leukemia
Beyond the preview
Go deeper on NCT00040690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040690.